Kabra Drugs Limited (BOM:524322)
India flag India · Delayed Price · Currency is INR
33.29
-0.64 (-1.89%)
At close: Feb 12, 2026

Kabra Drugs Balance Sheet

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Cash & Equivalents
116.1212.9926.710.030.010.1
Short-Term Investments
0.890.440.44---
Cash & Short-Term Investments
116.99213.4327.150.030.010.1
Cash Growth
460.19%686.23%91932.82%133.67%-87.10%-10.75%
Accounts Receivable
205.96.016.016612.55
Receivables
205.96.016.016.446.7213.26
Inventory
165.24-----
Other Current Assets
43.8732.1912.330.330.330.33
Total Current Assets
531.99251.6245.486.87.0613.69
Property, Plant & Equipment
7.050.44---0.1
Other Long-Term Assets
00.230.230.230.230.23
Total Assets
545.02252.2945.727.047.314.02
Accounts Payable
275.88----1.87
Short-Term Debt
4.694.3717.0913.8210.269
Other Current Liabilities
0.81.3717.80.530.975.22
Total Current Liabilities
284.635.7434.8914.3511.2316.1
Long-Term Deferred Tax Liabilities
0.010.01----
Other Long-Term Liabilities
0.47--000-
Total Liabilities
285.15.7434.8914.3511.2316.1
Common Stock
237.08237.0843.8943.8943.8943.89
Retained Earnings
22.849.47-58.56-51.2-47.82-45.96
Comprehensive Income & Other
--025.5---
Shareholders' Equity
259.92246.5510.83-7.31-3.93-2.08
Total Liabilities & Equity
545.02252.2945.727.047.314.02
Total Debt
4.694.3717.0913.8210.269
Net Cash (Debt)
112.29209.0610.06-13.79-10.25-8.91
Net Cash Growth
675.46%1977.87%----
Net Cash Per Share
5.8419.132.29-3.14-2.33-2.03
Filing Date Shares Outstanding
23.8523.714.394.394.394.39
Total Common Shares Outstanding
23.8523.714.394.394.394.39
Working Capital
247.36245.8810.6-7.54-4.16-2.41
Book Value Per Share
10.9010.402.47-1.67-0.90-0.47
Tangible Book Value
259.89246.5510.83-7.31-3.93-2.08
Tangible Book Value Per Share
10.8910.402.47-1.67-0.90-0.47
Machinery
-0.44-1.661.661.66
Source: S&P Global Market Intelligence. Standard template. Financial Sources.